Molecular biomarkers and site of first recurrence after radiotherapy for head and neck cancer
Open Access
- 31 December 2004
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 40 (18), 2734-2741
- https://doi.org/10.1016/j.ejca.2004.08.019
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Altered fractionation and combined radio-chemotherapy approachesEuropean Journal Of Cancer, 2003
- Failure-specific prognostic factors after continuous hyperfractionated accelerated radiotherapy (CHART) or conventional radiotherapy in locally advanced non-small-cell lung cancer: A competing risks analysisBritish Journal of Cancer, 2001
- Molecular markers predictive of response and prognosis in the patient with advanced squamous cell carcinoma of the head and neck: evolution of a model beyond TNM stagingCurrent Opinion in Oncology, 2000
- Molecular markers as prognostic factors for local recurrence and radioresistance in head and neck squamous cell carcinomaRadiation Oncology Investigations, 1999
- Competing risks analyses for recurrence from primary breast cancerBritish Journal of Cancer, 1999
- Towards evidence based radiation oncology: improving the design, analysis, and reporting of clinical outcome studies in radiotherapyRadiotherapy and Oncology, 1998
- A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancerRadiotherapy and Oncology, 1997
- Tumour proliferation assessed by combined histological and flow cytometric analysis: implications for therapy in squamous cell carcinoma in the head and neckBritish Journal of Cancer, 1992
- Competing events determining relapse-free survival in limited small-cell lung carcinoma. The French Cancer Centers' Lung Group.Journal of Clinical Oncology, 1992
- A Covariate Model for Partially Censored Data Subject to Competing Causes of FailureJournal of the Royal Statistical Society Series C: Applied Statistics, 1978